antiarrhythmia drugs 2 Flashcards

1
Q

direct results of block of L-type Ca2+ channels are?

A
  1. Slowed upstroke

2. reduced AP amplitude

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What results indirectly from L channel block?

A

Slowed repolarization (phase 3)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

In SA and AV node, adenosine (via A1 adenosine receptor) works to?

A
  1. ↑ K+ current
  2. ↓ L-type Ca2+ current (dihydropyridine-sensitive, slow inward current)
  3. ↓ If in SA and AV nodes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

adenosine action

A

similar to β-adrenergic receptor blockers, but adenosine is not a β-blocker.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Adenosine-induced changes in membrane currents:

A

↓ SA node and AV node firing rate

↓ conduction rate in the AV node

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Antiarrhythmic drugs are primary therapy for

A
  1. atrial fibrillation only

2. Ablation or ICD equal or superior in management of all other arrhythmias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

PSVT: tx acute with

A

adenosine (short half-life is advantageous)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

PSVT: tx chronic with

A
  1. AV nodal blockers
  2. Class II (β-blockers)
  3. Class IV (Ca2+ channel blockers)
  4. Class III (amiodarone, sotalol)
  5. catheter ablation of ectopic focus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Ventricular tachycardias/fibrillation pathophysiology via

A

afterdepolarizations + re-entry

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Ventricular tachycardias/fibrillation: treat acute with

A
  1. amiodarone

2. lidocaine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

esmolol metabolize by

A

blood esterase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

amiodarone side effects

A
  1. heart block
  2. thyroid dysfunction
  3. corneal deposits
  4. pulmonary fibrosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Drug prevention of sudden cardiac death:

Proven benefit

A
  1. β-blockers
  2. angiotensin converting enzyme (ACE) inhibitors
  3. aspirin
  4. statins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Drug prevention of sudden cardiac death:

perhaps benefit

A
  1. amiodarone

2. digoxin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Drug prevention of sudden cardiac death:

perhaps harmful

A
  1. Class I drugs (Na+ channel blockers)

2. Class IV drugs (Ca2+ channel blockers)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Procainamide major side effect

A
  1. Lupus syndrome (occurs in 1/3 of patients on long-term therapy).
  2. class Ia
17
Q

Lidocaine major side effects

A
  1. Least cardiotoxic agent of Class I drugs.
  2. Side effects: paresthesia, tremors, seizures, agitation, confusion.
  3. class Ib
18
Q

Flecainide and Propafenone Major side effects

A
  1. Highly pro-arrhythmic, particularly with ventricular tachycardia.
  2. class Ic
19
Q

B-blocker major side effects

A
  1. Hypotension
  2. aggravation of heart failure
  3. bronchospasm
  4. impotence.
20
Q

amiodarone major side effects

A
  1. Cardiac problems include bradycardia and heart block.
  2. Dose-related effects include:
    a. thyroid dysfunction,
    b. corneal deposits,
    c. pulmonary fibrosis and
    d. skin discoloration.
  3. Problems with side effects are exacerbated by the very long half-life of amiodarone (13-100 days).
  4. Class 3
21
Q

sotalol major side effects

A
  1. Structurally, this drug is a β-adrenergic receptor ligand.
  2. Principal side effects are similar to those of the other β-blockers.
  3. class 3
22
Q

verapamil major side effects

A
  1. The major adverse effect of these drugs is hypotension
    (via action on vascular smooth muscle.)
  2. Negative cardiac inotropy
  3. class 4
23
Q

what explains adenosine’s side effects?

A

Adenosine action on coronary circulation